Skip to Main Content
Skip Nav Destination

Although molecular diagnosis in cancer has advanced over the last decades translation into successful therapies of solid cancers is lagging behind. In this chapter we will provide insights into the molecular analysis of single disseminated tumour cells (DTCs) – a cell population that comprises the founder cells of lethal metastasis. Here, recent data challenge the traditional approach of using the primary tumour as the surrogate marker for the selection of adjuvant therapies and emphasize the need to understand the biology of systemic cancer progression for personalized targeted therapies.

This content is only available via PDF.
You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal